相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activation of p53 mediated glycolytic inhibition-oxidative stress-apoptosis pathway in Dalton's lymphoma by a ruthenium (II)-complex containing 4-carboxy N-ethylbenzamide
Raj Kumar Koiri et al.
BIOCHIMIE (2015)
Antiangiogenic ruthenium(II) benzimidazole complexes, structure-based activation of distinct signaling pathways
Haoqiang Lai et al.
METALLOMICS (2015)
Preclinical combination therapy of the investigational drug NAMI-A+ with doxorubicin for mammary cancer
Alberta Bergamo et al.
INVESTIGATIONAL NEW DRUGS (2015)
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
Suzanne Leijen et al.
INVESTIGATIONAL NEW DRUGS (2015)
BRCA1-IRIS inactivation sensitizes ovarian tumors to cisplatin
B. T. Paul et al.
ONCOGENE (2015)
Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer
Q. H. Miow et al.
ONCOGENE (2015)
Combination therapy with carboplatin and thalidomide suppresses tumor growth and metastasis in 4T1 murine breast cancer model
Cristina Maria de Souza et al.
BIOMEDICINE & PHARMACOTHERAPY (2014)
Src activity is modulated by oxaliplatin and correlates with outcomes after hepatectomy for metastatic colorectal cancer
Scott Kopetz et al.
BMC CANCER (2014)
Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer
A. F. Hezel et al.
BRITISH JOURNAL OF CANCER (2014)
Effects of polymorphisms in the XRCC1, XRCC3, and XPG genes on clinical outcomes of platinum-based chemotherapy for treatment of non-small cell lung cancer
Z. Y. Jin et al.
GENETICS AND MOLECULAR RESEARCH (2014)
Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer
N. G. Alkema et al.
GYNECOLOGIC ONCOLOGY (2014)
Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin
Jennifer M. Scalici et al.
GYNECOLOGIC ONCOLOGY (2014)
Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status
Shikha Gaur et al.
MOLECULAR CANCER (2014)
BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis
Mateusz Rytelewski et al.
MOLECULAR ONCOLOGY (2014)
Arene ruthenium(II) complex, a potent inhibitor against proliferation, migration and invasion of breast cancer cells, reduces stress fibers, focal adhesions and invadopodia
Qiong Wu et al.
METALLOMICS (2014)
Oxaliplatin-Based Chemotherapy Is More Beneficial in KRAS Mutant than in KRAS Wild-Type Metastatic Colorectal Cancer Patients
Yu-Lin Lin et al.
PLOS ONE (2014)
Upregulation of miR-21 in Cisplatin Resistant Ovarian Cancer via JNK-1/c-Jun Pathway
Ileabett M. Echevarria-Vargas et al.
PLOS ONE (2014)
Withaferin A Alone and in Combination with Cisplatin Suppresses Growth and Metastasis of Ovarian Cancer by Targeting Putative Cancer Stem Cells
Sham S. Kakar et al.
PLOS ONE (2014)
In vivo anti-tumor activity of the organometallic ruthenium(II)-arene complex [Ru(η6-p-cymene)-Cl2(pta)] (RAPTA-C) in human ovarian and colorectal carcinomas
Andrea Weiss et al.
CHEMICAL SCIENCE (2014)
Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis
Dinesh Vyas et al.
ONCOTARGETS AND THERAPY (2014)
Systems biology of cisplatin resistance: past, present and future
L. Galluzzi et al.
CELL DEATH & DISEASE (2014)
Targeted Inhibition of mTOR Signaling Improves Sensitivity of Esophageal Squamous Cell Carcinoma Cells to Cisplatin
Guiqin Hou et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?
Christen L Walters Haygood
World Journal of Stem Cells (2014)
Docetaxel-cisplatin might be superior to docetaxel-capecitabine in the first-line treatment of metastatic triple-negative breast cancer
Y. Fan et al.
ANNALS OF ONCOLOGY (2013)
Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis
J. Lee et al.
BRITISH JOURNAL OF CANCER (2013)
Activation of p53 pathway by Nutlin-3a inhibits the expression of the therapeutic target α5 integrin in colon cancer cells
Hana Janouskova et al.
CANCER LETTERS (2013)
Mechanisms Governing Metastatic Dormancy and Reactivation
Filippo G. Giancotti
CELL (2013)
Effects of chrysin, apigenin, genistein and their homoleptic copper(II) complexes on the growth and metastatic potential of cancer cells
Cornelia Spoerlein et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2013)
Imaging VCAM-1 as an Indicator of Treatment Efficacy in Metastatic Ovarian Cancer
Jennifer M. Scalici et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Impacts of fullerene derivatives on regulating the structure and assembly of collagen molecules
Xiaohui Yin et al.
NANOSCALE (2013)
Influence of tumour micro-environment heterogeneity on therapeutic response
Melissa R. Junttila et al.
NATURE (2013)
Epimorphin-Induced MET Sensitizes Ovarian Cancer Cells to Platinum
Kok-Hooi Yew et al.
PLOS ONE (2013)
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients
Mario Scartozzi et al.
PHARMACOGENOMICS (2013)
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Min Yu et al.
SCIENCE (2013)
Role of ABCG2 expression driven by cisplatin in platinum-containing chemotherapy for gastric cancer
Qiang Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
H. J. Schmoll et al.
ANNALS OF ONCOLOGY (2012)
Anti-metastatic and Anti-angiogenic Properties of Potential New Anti-cancer Drugs Based on Metal Complexes of Selenosemicarbazones
Manja Zec et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2012)
CDK1 Hyperphosphorylation Maintenance Drives the Time-course of G2-M Cell Cycle Arrest after Short Treatment with NAMI-A in Kb Cells
Alberta Bergamo et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2012)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
Role of stromal microenvironment in nonpharmacological resistance of CML to imatinib through Lyn/CXCR4 interactions in lipid rafts
Y. Tabe et al.
LEUKEMIA (2012)
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Ravid Straussman et al.
NATURE (2012)
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
Timothy R. Wilson et al.
NATURE (2012)
Combinatorial drug therapy for cancer in the post-genomic era
Bissan Al-Lazikani et al.
NATURE BIOTECHNOLOGY (2012)
Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia
Wan Zhang et al.
NATURE CELL BIOLOGY (2012)
A family business: stem cell progeny join the niche to regulate homeostasis
Ya-Chieh Hsu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Distinct cellular fates for KP1019 and NAMI-A determined by X-ray fluorescence imaging of single cells
Jade B. Aitken et al.
METALLOMICS (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
Bone Marrow Stromal Cells Modulate Mouse ENT1 Activity and Protect Leukemia Cells from Cytarabine Induced Apoptosis
Patricia Macanas-Pirard et al.
PLOS ONE (2012)
Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial
A. Flechon et al.
ANNALS OF ONCOLOGY (2011)
Developmental and Pathological Angiogenesis
Alicia S. Chung et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
A cyclopalladated complex interacts with mitochondrial membrane thiol-groups and induces the apoptotic intrinsic pathway in murine and cisplatin-resistant human tumor cells
Fabiana A. Serrano et al.
BMC CANCER (2011)
Macrophage Binding to Receptor VCAM-1 Transmits Survival Signals in Breast Cancer Cells that Invade the Lungs
Qing Chen et al.
CANCER CELL (2011)
Loss or Inhibition of Stromal-Derived PIGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1+ Leukemia
Thomas Schmidt et al.
CANCER CELL (2011)
Bone Marrow Stroma-Secreted Cytokines Protect JAK2V617F-Mutated Cells from the Effects of a JAK2 Inhibitor
Taghi Manshouri et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Dialkyl Bisphosphonate Platinum(II) Complex as a Potential Drug for Metastatic Bone Tumor
Hidetoshi Nakatake et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2011)
Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs
Alberta Bergamo et al.
DALTON TRANSACTIONS (2011)
Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
Tanaya Shree et al.
GENES & DEVELOPMENT (2011)
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
Sergio A. Quezada et al.
IMMUNOLOGICAL REVIEWS (2011)
Organometallic ruthenium-based antitumor compounds with novel modes of action
Wee Han Ang et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2011)
Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial
Matthew T. Seymour et al.
LANCET (2011)
Fibroblasts Contribute to Melanoma Tumor Growth and Drug Resistance
Edward H. Flach et al.
MOLECULAR PHARMACEUTICS (2011)
Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment
Jonathan W. Wojtkowiak et al.
MOLECULAR PHARMACEUTICS (2011)
Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatin
Michael Groessl et al.
METALLOMICS (2011)
KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma
T. Jiffar et al.
ONCOGENE (2011)
Microenvironmental Influence on Pre-Clinical Activity of Polo-Like Kinase Inhibition in Multiple Myeloma: Implications for Clinical Translation
Douglas W. McMillin et al.
PLOS ONE (2011)
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
David G. DeNardo et al.
CANCER DISCOVERY (2011)
Sublethal concentrations of the platinum(II) complex [Pt(O,O'-acac)(γ-acac)(DMS)] alter the motility and induce anoikis in MCF-7 cells
Antonella Muscella et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Gold(III) porphyrin 1a inhibited nasopharyngeal carcinoma metastasis in vivo and inhibited cell migration and invasion in vitro
Ching Tung Lum et al.
CANCER LETTERS (2010)
Contextual Synthetic Lethality of Cancer Cell Kill Based on the Tumor Microenvironment
Norman Chan et al.
CANCER RESEARCH (2010)
Platinum-DNA Interactions and Subsequent Cellular Processes Controlling Sensitivity to Anticancer Platinum Complexes
Saeed Ahmad
CHEMISTRY & BIODIVERSITY (2010)
Neoplastic stem cells: Current concepts and clinical perspectives
Axel Schulenburg et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2010)
Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer
N. Ahmed et al.
CURRENT CANCER DRUG TARGETS (2010)
The status of platinum anticancer drugs in the clinic and in clinical trials
Nial J. Wheate et al.
DALTON TRANSACTIONS (2010)
Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinoma
Pasqualino Malandrino et al.
ENDOCRINE-RELATED CANCER (2010)
Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
Mitomu Kioi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma
Jo Eyles et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Synthesis, structure and characterization of novel Cd(II) and Zn(II) complexes with the condensation product of 2-formylpyridine and selenosemicarbazide Antiproliferative activity of the synthesized complexes and related selenosemicarbazone complexes
Snezana Bjelogrlic et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2010)
Arsenic Trioxide overcomes cell adhesion-mediated drug resistance through down-regulating the expression of beta(1)-integrin in K562 chronic myelogenous leukemia cell line
Wang Guo-Bao et al.
LEUKEMIA & LYMPHOMA (2010)
Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity
Douglas W. McMillin et al.
NATURE MEDICINE (2010)
Effects of Bone Marrow Stromal Cells and Umbilical Cord Blood-Derived Stromal Cells on Daunorubicin-Resistant Residual Jurkat Cells
X. Liang et al.
TRANSPLANTATION PROCEEDINGS (2010)
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2009)
Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study
Frederike Lentz et al.
ANTI-CANCER DRUGS (2009)
Mechanisms of anti-cancer action and pharmacology of clofarabine
Anna Zhenchuk et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells
D. L. Roberts et al.
BRITISH JOURNAL OF CANCER (2009)
Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma
Youling Gong et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Acute myelogenous leukemia
Joshua L. Shipley et al.
EXPERIMENTAL HEMATOLOGY (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Microenvironmental regulation of metastasis
Johanna A. Joyce et al.
NATURE REVIEWS CANCER (2009)
Attenuated p53 activation in tumour-associated stromal cells accompanies decreased sensitivity to etoposide and vincristine
A. C. Dudley et al.
BRITISH JOURNAL OF CANCER (2008)
Subtypes of breast cancer show preferential site of relapse
Marcel Smid et al.
CANCER RESEARCH (2008)
Targeted therapeutics for cancer treatment: major progress towards personalised molecular medicine
Paul Workman et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
A 1,2-d(GpG) cisplatin intrastrand cross-link influences the rotational and translational setting of DNA in nucleosomes
Matthias Ober et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance
Nadine N. Bewry et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Chemotherapeutic treatment of bone marrow stromal cells strongly affects their protective effect on acute myeloid leukemia cell survival
Bijan Moshaver et al.
LEUKEMIA & LYMPHOMA (2008)
ATF6α-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo
Denis M. Schewe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Models, mechanisms and clinical evidence for cancer dormancy
Julio A. Aguirre-Ghiso
NATURE REVIEWS CANCER (2007)
Recent advances involving palladium (II) complexes for the cancer therapy
Antonio Carlos Favero Caires
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2007)
Prostate specific antigen recurrence after definitive therapy
Stephen J. Freedland et al.
JOURNAL OF UROLOGY (2007)
Genetic determinants of cancer metastasis
Don X. Nguyen et al.
NATURE REVIEWS GENETICS (2007)
Biochemical Mechanisms of Cisplatin Cytotoxicity
Victoria Cepeda et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2007)
Ruthenium complexes can target determinants of tumour malignancy
A. Bergamo et al.
DALTON TRANSACTIONS (2007)
Studies of a cobalt(III) complex of the MMP inhibitor marimastat: A potential hypoxia-activated prodrug
Timothy W. Failes et al.
CHEMISTRY-A EUROPEAN JOURNAL (2007)
Inhibition of B16 melanoma metastases with the ruthenium complex imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate and down-regulation of tumor cell invasion
B Gava et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Testicular germ cell tumours: The paradigm of chemo-sensitive solid tumours
A di Pietro et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Platinum anticancer drug damage enforces a particular rotational setting of DNA in nucleosomes
AJ Danford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Integrin signaling in malignant melanoma
S Kuphal et al.
CANCER AND METASTASIS REVIEWS (2005)
Chiral cyclopalladated complexes derived from N,N-dimethyl-1-phenethylamine with bridging bis(diphenylphosphine)ferrocene ligand as inhibitors of the cathepsin B activity and as antitumoral agents
C Bincoletto et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Recent advances in the treatment of testicular cancer
RA Huddart et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2005)
TGFβ1 regulation and collagen-release-independent connective tissue re-modelling by the ruthenium complex NAMI-A in solid tumours
C Casarsa et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
Intratumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and tumor infiltrating lymphocyte recruitment
S Pacor et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Vanadium(III) complexes with L-cysteine -: stability, speciation and the effect on actin in hepatoma Morris 5123 cells
I Osinska-Królicka et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
Cytotoxicity of the organic ruthenium anticancer drug Nami-A is correlated with DNA binding in four different human tumor cell lines
D Pluim et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
Actin-dependent tumour cell adhesion after short-term exposure to the antimetastasis ruthenium complex NAMI-A
G Sava et al.
EUROPEAN JOURNAL OF CANCER (2004)
A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent
JM Rademaker-Lakhai et al.
CLINICAL CANCER RESEARCH (2004)
Solid state and solution studies of a vanadium(III)-L-cysteine compound and demonstration of its antimetastatic, antioxidant and inhibition of neutral endopeptidase activities
A Papaioannou et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules
BJ Moeller et al.
CANCER CELL (2004)
Evidence emerges for early metastasis and parallel evolution of primary and metastatic tumors
JW Gray
CANCER CELL (2003)
From latent disseminated cells to overt metastasis:: Genetic analysis of systemic breast cancer progression
O Schmidt-Kittler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The attractive Achilles heel of germ cell tumours: an inherent sensitivity to apoptosis-inducing stimuli
DCJ Spierings et al.
JOURNAL OF PATHOLOGY (2003)
Gene expression profiles of human breast cancer progression
XJ Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Antianglogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers
L Morbidelli et al.
BRITISH JOURNAL OF CANCER (2003)
Role of the extracellular and cytoplasmic domains of CD44 in the rolling interaction of lymphoid cells with hyaluronan under physiologic flow
I Gál et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Primary tumor, lung and kidney retention and antimetastasis effect of NAMI-A following different routes of administration
M Cocchietto et al.
INVESTIGATIONAL NEW DRUGS (2003)
A molecular signature of metastasis in primary solid tumors
S Ramaswamy et al.
NATURE GENETICS (2003)
Inhibition of the MEK/ERK signaling pathway by the novel antimetastatic agent NAMI-A down regulates c-myc gene expression and endothelial cell proliferation
G Pintus et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis
A Yamaguchi et al.
JOURNAL OF SURGICAL ONCOLOGY (2002)
Inhibition of endothelial cell functions and of angiogenesis by the metastasis inhibitor NAMI-A
A Vacca et al.
BRITISH JOURNAL OF CANCER (2002)
Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A
G Sava et al.
EUROPEAN JOURNAL OF CANCER (2002)
Urokinase receptor and fibronectin regulate the ERKMAPK to p38MAPK activity ratios that determine carcinoma cell proliferation or dormancy in vivo
JA Aguirre-Ghiso et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
